Showing 2,821 - 2,840 results of 134,598 for search '(( a d decrease ) OR ( 5 ((((mean decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.59s Refine Results
  1. 2821

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”
  2. 2822
  3. 2823
  4. 2824

    <i>In vivo</i> effects of DJ-V-159. by Min Pi (375625)

    Published 2018
    “…<p>(A) The effects of DJ-V-159 on GPRC6A-mediated regulation of insulin secretion in mouse β-cells, MIN-6. …”
  5. 2825
  6. 2826
  7. 2827
  8. 2828
  9. 2829
  10. 2830
  11. 2831
  12. 2832

    (R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
  13. 2833
  14. 2834

    Fig 9 - by Jianbo Jia (717814)

    Published 2024
    Subjects:
  15. 2835
  16. 2836
  17. 2837
  18. 2838
  19. 2839
  20. 2840

    Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

    Published 2020
    “…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”